Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.24% | 43.22% | 19.01% | 26.58% | 27.16% |
| Total Depreciation and Amortization | 242.11% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.23% | -89.64% | -89.41% | -88.29% | -89.29% |
| Change in Net Operating Assets | -237.25% | -205.38% | -135.39% | -113.55% | -87.51% |
| Cash from Operations | -32.88% | -82.68% | -249.29% | -302.64% | -69,675.44% |
| Capital Expenditure | -379.22% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.19% | 118.97% | 102.59% | -188.81% | -321.78% |
| Cash from Investing | 81.97% | 118.37% | 102.34% | -146.04% | -336.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,950.47% | -99.95% | -99.95% | -99.78% | -98.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.60% | 65.60% | 65.60% | -- | -- |
| Cash from Financing | 4,384.73% | -100.01% | -100.02% | -99.97% | -98.21% |
| Foreign Exchange rate Adjustments | -- | -47.83% | -100.00% | 75.32% | 115.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.76% | 72.81% | -776.15% | -235.52% | -201.32% |